Program for the prevention of infection-related premature births: The role of the Lactobacilli system and vaginal pH

Infectious Pregnancy Complications

Volumn , Issue , 2009, Pages 167-198

  Saling, Erich ^a   Dräger, Monika ^a  

^a Institute of Perinatal Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959930546     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (89)

1. Berkowitz GS, Papiernick E. (1993): Epidemiology of preterm birth. Epidemiol. Rev. 15 (2) 414-443.
2. Hack M, Taylor HG, Klein N, Eiben R, Schatschneider C, Mercuri-Minich N (1994): School-age outcomes in children with birth weights under 750g. N. Engl. J. Med. 331: 753-759.
3. Edwards WH, Little GA (1998): Outcome of the very-low-birth-weight baby: an American experience. In: Kurjak A: Textbook of perinatal medicine: a comprehensive guide to modern clinical perinatology. 1. Perinatology. Parthenon Publishin Group: S. 141-1152
4. Saigal S, Rosenbaum P, Hattersley B, Milner R (1989): Decreased disability rate among 3-year-old survivors weighing 501 to 1000 grams at birth and born to residents of a geographically defined region from 1981 to 1984 compared with 1977 to 1980. J. Pediatr. 114: 839-846.
5. Hack M, Wright LL, Shankaran S, Tyson JE, Horbar JD, Bauer CR, Younes N (1995): Very-low-birth-weight outcomes of the National Institute of Child Health and Human Development Neonatal Network, November 1989 to October 1990. Am. J. Obstet. Gynecol. 172: 457-464.
6. Monset-Couchard M, de Bethmann O, Kastler B (1996): Mid-and long-term outcome of 89 premature infants weighing less than 1000 g at birth, all appropriate for gestational age. Biol. Neonate 70: 328-338.
7. Wolke D, Meyer R (1994): Psychologische Langzeitbefunde bei sehr Frühgeborenen. PerinatalMedizin 6: 121-123.
8. Wolke D (1998): Psychological development of prematurely born children. Arch. Dis. child 78: 567-570.
9. Bundesgeschäftsstelle Qualitätssicherung (several years): BQS-Bundesauswertung http://www.bqs-outcome.de/
10. Martin JA, Hamilton BE, Sutton PD, et al. (2005): Births: Final data for 2003. National vital statistics reports; vol 54 no 2. Hyattsville, MD: National Center for Health Statistics. 2005. Available at: http://www.cdc.gov/nchs/data/nvsr/nvsr54/nvsr54_02.pdf.
11. Institute of Medicine of the National Academies (2007): Preterm Birth: Causes, Consequences, and Prevention. Richard E. Behrman and Adrienne Stith Butler, Editors. The National Academies Press, Washington, D.C. http://books.nap.edu/openbook.php?record_id=11622andpage=1.
12. Romero R, Avila C, Brekus CA, Mazor M. (1990): The Role of Systemic and Intrauterine Infection in Preterm Parturition. In: Garfiel RE (ed.): Uterine contractility, 319-353.
13. Romero R, Mazor M, Munoz H, Gomez R, Galasso M, Sherer DM (1994): The preterm labor syndrome. Ann. N Y Acad. Sci. 734: 414-429.
14. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M (2006b): The preterm parturition syndrome. Br. J. Obstet. Gyneacol. 113 (Suppl. 3): 17-42.
15. Saling E (1981): Der frühe totale Muttermundverschluß zur Vermeidung habitueller Aborte und Frühgeburten. Z Geburtshilfe Perinat 185: 259-261.
16. Saling E (1984): Prevention of habitual abortion and prematurity by early total occlusion of the external os uteri. Eur. J. Obstet. Gynecol. Reprod. Biol. 17: 165-170.
17. Saling E, Brandt-Niebelschütz S, Schmitz C (1991): Vermeidung von Spätaborten und risikoreichen Frühgeburten-für die Routine geeignete Maßnahmen. Z. Geburtshilfe Perinat. 195: 209-221.
18. Saling E (1991): Program for the Prevention of Prematurity. In: Hirsch HA: Infection and Preterm Labor (International Symposium Tübingen, 1990) Thieme, Stuttgart -New York.
19. Romero R, Gomez R, Baumann P, Mazor M, Cotton D (1993): The role of the infection and cytokines in preterm parturition. In: Chwalisz K and Garfield RE: Basic Mechanismus controlling term and preterm birth; Ernst Schering Research Foundation, workshop 7; Springer, Berlin Heidelberg, New York: 197-240.
20. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM (1998): The fetal inflammatory response syndrome. Am. J. Obstet. Gynecol. 179: 194-202.
21. Mays JK, Figueroa R, Shah J, Khakoo H, Kaminsky S, Tejani N (2000): Amniocentesis for selection before rescue cerclage. Obstet Gynecol 95: 652-655.
22. Romero R, Gonzalez R, Sepulveda W, Brandt F, Ramirez M, Sorokin Y, Mazor M, Treadwell MC, Cotton DB (1992): Infection and labor. VIII. Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence: prevalence and clinical significance. Am. J. Obstet. Gynecol. 167 (4 Pt 1): 1086-1091.
23. Mazor M, Hershkovitz R, Ghezzi F, Maymon E, Horowitz S, Leiberman JR (1996): Intraamniotic infection in patients with preterm labor and twin pregnancies. Acta Obstet Gynecol. Scand. 75: 624-627.
24. Martius J, Eschenbach DA (1990): The role of bacterial vaginosis as a cause of amniotic fluid infection, choriamnionitis and prematurity -a review. Arch. Gynecol. Obstet. 247: 1-13.
25. Koumans EH, Kendrick JS, CDC Bacterial Vaginosis Working Group (2001): Preventing adverse sequelae of bacterial vaginosis: a public health program and research agenda. Sex Transm Dis 28 (5): 292-297.
26. Eschenbach DA, Hillier S, Critchlow C, Stevens C, DeRouen T, Holmes KK (1988). Diagnosis and clinical manifestations of bacterial vaginosis. Am. J. Obstet. Gynecol. 158: 819-828.
27. Donders G G G, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B (2002): Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. Br. J. Obstet Gynecol. 109: 34-43.
28. Martius J (1998): Infektionen. In: Martius G, Rath W: Praxis der Frauenheilkunde, Band 3: Geburtshilfe und Perinatologie. Thieme Stuttgart, New York, S. 304-339.
29. Romero R, Chairworapongsa T, Kuivaniemi H, Tromp G (2004): Bacterial vaginosis, the inflammatory response and the risk of preterm birth: A role for genetic epidemiology in the prevention of preterm birth. Am. J. Obstet. Gynecol. 190: 1509-19.
30. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL (1992): A review of premature birth and subclinical infection. Am. J. Obstet. Gynecol. 166: 1515-1528.
31. Kouam L, Kamdom-Moyo J (1995): Frühgeburtenrate und perinatale Mortalität an der Universitätsfrauenklinik Yaoundé (Kamerun) von 1982-1992. Eine Analyse von 680 Fällen. Z. Geburtshilfe Neonatol. 199: 65-70.
32. Offenbacher S, Beck JD, Lieff S, Slade G (1998): Role of periodontitis in systemic health: sponstaneous preterm birth. J. Dent. Educ 62 (19): 852-858.
33. Xiong X, Buekens P, Fraser WD, Beck J, Offenbacher S (2006): Periodontal disease and adverse pregnancy outcomes: a systematic review. Br. J. Obstet Gynecol. 113:135-143.
34. Döderlein A (1892): Das Scheidensekret und seine Bedeutung für das Puerperalfieber. Verlag von Eduard Besold, Leipzig.
35. Reid G (2001): Probiotic agents to protect the urogenital tract against infection. Am. J. Clin. Nutr. 73 (suppl): 437S-443S.
36. Hillier SL, Krohn MA, Klebanoff SJ, Eschenbach DA (1992a): The relationship of hydrogen peroxide producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet. Gynecol. 79 (3): 369-373.
37. Ernest JM, Meis PJ, Moore ML, Swain M (1989): Vaginal pH: A marker of preterm premature rupture of the membranes. Obstet. Gynecol. 74: 734-737.
38. Schumacher E (1999): Infektionsbezogene diagnostische Parameter bei Patientinnen mit Frühgeburtsymptomatik. Dissertation an der Freien Universität Berlin.
39. Hengst P, Uhlig B, Bollmann R, Kokott Th (1992): Nutzen der vaginalen pH-Messung zur Frühgeburtsvermeidung. Ergebnisse einer prospektiven Studie. Z Geburtshilfe Perinat 196: 238-241.
40. Saling E, Fuhr N, Placht A, Schumacher E (1995): Erste Ergebnisse der "SelbstVorsorge-Aktion von Schwangeren" zur Frühgeburtenvermeidung. Arch. Gynecol. Obstet. 257: 178-185.
41. Hillier SL, Krohn MA, Nugent RP, Gibbs RS (1992b): Characteristics of three vaginal flora patterns assessed by Gram stain among pregnant women. Am. J. Obstet. Gynecol. 166: 938-944
42. Schröder R (1921): Zur Pathogenese und Klinik des vaginalen Fluors. Zentralbl. Gynakol. 38: 1350-1361.
43. Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J (1994): Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 308: 295-298.
44. Viehweg B, Junghans U, Stephan H, Voigt Th, Faber R (1997): Der Nutzen vaginaler pH-Messungen für die Erkennung potentieller Frühgeburten. Zentralbl Gynakol 119: 33-37.
45. Saling E, Schreiber M (2005): Laktobazillen-Schutzsystem bei Schwangeren-effiziente Vermeidung von Frühgeburten durch Früherkennung von Störungen. Z Geburtshilfe Neonatol. 209: 128-134.
46. Saling E (1990b): Zusätzliche aktuelle Maßnahmen zur Vermeidung von Spätaborten und Frühgeburten. In: Dudenhausen JW, Saling E: Perinatale Medizin, Bd. XIII (14. Deutscher Kongreß für Perinatale Medizin, Berlin 3.-6.10.1989). Thieme, Stuttgart -New York.
47. Amsel R, Totten PA, Spiegel CA, Chen KCS, Eschenbach D, Holmes KK (1983): Nonspecific vaginitis. Am. J. Med. 74: 14-22.
48. Saling E (1992): Current Measures to Prevent Late Abortion or Prematurity. In: Saling, E.: Perinatology. Nestlé Nutrition Workshop Series, Vol. 26. Raven Press, New York.
49. Alvarez-Olmos MI, Oberhelman RA (2001): Probiotic Agents and Infectious Diseases: A Modern Perspective on a Traditional Therapy. Clin. Infect. Dis. 32: 1567-1576.
50. AWMF online (2008): Bakterielle Vaginose in Gynäkologie und Geburtshilfe. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), Arbeitsgemeinschaft Infektiologie und Infektionsimmunologie in der Gynäkologie und Geburtshilfe (AGII). http://www.uni-duesseldorf.de/AWMF/ll/015-028.htm(firstpublished:08/2001lastreview:06/2008).
51. Lamont RF, Duncan SL, Mandal D, Basset P (2003): Intravaginal Clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet. Gynecol. 101: 516-522.
52. Leitich H, Brunbauer M, Bodner-Adler B, Kaider A, Egarter C, Husslein P (2003): Antibiotic treatment of bacterial vaginosis in pregnancy: A meta-analysis. Am. J. Obstet. Gynecol. 188: 752-758.
53. Okun N, Gronau KA, Hannah ME (2005): Antibiotics for Bacterial Vaginosis or Trichomonas vaginalis in pregnancy: a systemic review. Obstet. Gynecol. 105: 857868.
54. Friese K, Neumann G, Siebert J, Harke HP, Kirschner W (2000): Vergleich zweier lokaler Antiseptika in der klinischen Anwendung bei bakteriell bedingten Vaginalinfektionen. Geburtsh. Frauenheilk. 60: 308-313
55. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL (1995): Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N. Engl. J. Med. 333 (26): 1732-1736.
56. Carey JC, Klebanoff MA Hauth JC et al. (2000): Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N. Engl. J. Med. 342: 534-540.
57. McDonald HM, O'Loughlin JA, Vigneswaran R, Jolley PT, Harvey JA, Bof A, McDonald PJ. (1997): Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial. Br. J. Obstet. Gynaecol. Dec;104(12):1391-7.
58. Varma R, Gupta JK, James DK, Kilby MD (2006a): Do screening-preventative interventions in asymptomatic pregnancies reduce the risk of preterm delivery-A critical appraisal of the literature. Eur. J. Obstet. Gynecol. Reprod. Biol. 127: 145-159.
59. Varma R, Gupka JK (2006b): Antibiotic treatment of bacterial vaginosis in pregnancy: Multiple meta-analysis and dilemmas in interpretation. Europ J. Obstet. Gynecol. Reprod. Biolog. 124: 10-14.
60. Parent D, Bossens M, Bayot D, Kirkpatrick C, Graf F, Wilkinson FE, Kaiser RR (1996): therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlles multicentric clinical trial. Arzneimittelforschung 46 (1): 68-73.
61. Hallén A, Jarstrand C, Påhlson C (1992): Treatment of bacterial vaginosis with lactobacilli. Sex Transm. Dis. 19 (3): 146-148.
62. Neri A, Sabah G, Samra Z (1993): Bacterial vaginosis in pregnancy treated with yoghurt. Acta Obstet. Gynecol. Scand. 72: 17-19.
63. Andersch B, Lindell D, Dahlen I, Brandberg A (1990): Bacterial Vaginosis and the Effect of Intermittent Prophylaktic Treatment with an Acid Lactate Gel. Gynecol. Obstet. Invest 30: 114-119.
64. Dennemark N, Meyer-Wilmes M, Schlüter R (1997): Screening and treatment of bacterial vaginosis in the early second trimester of pregnany: a sufficient measure for prevention of preterm deliveries? Int. J. STD AIDS Vol 8 Supplement 1: 38-40.
65. Kenyon S, Pike K, Jones DR, Brocklehurst P, Marlow N, Salt A, Taylor DJ (2008a): Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet 372 (9646): 1310-1308.
66. Kenyon S, Pike K, Jones DR, Brocklehurst P, Marlow N, Salt A, Taylor DJ (2008b): Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labor: 7-year follow-up of the ORACLE II trial. Lancet 372 (9646): 1319-1327.
67. Di Renzo GC, Cutuli A, Liotta L, Burnelli L, Luzi G (2006): Management of preterm labor: pharmacological and non-pharmacological aspects. In: Kurjak A., Chervenak FA.: Textbook of Perinatal Medicine. Informa Healthcare, Second Edition 2006 pp. 1394-1400.
68. Saling E (1998): Basic aspects of prematurity prevention and results achieved by a suitable, simple program. J. Perinat. Med. 26: 466-468.
69. Saling E, Al-Taie T, Lüthje J, Masur W, Placht A (1998): Efficient and simple program including community-based activities for prevention of very small prematures. In: Kurjak A (ed.): Textbook of Perinatal Medicine. London, New York. 1337-1344.
70. Saling E, Schreiber M, Al-Taie T (2001a): A simple, efficient and inexpensive program for preventing prematurity. J. Perinat. Med. 29: 199-211.
71. Riedewald S, Hanifi-Afshar T, Saling E (1992): pH-Selbstmessung in der Vagina durch die Schwangere (im Vergleich zu Kontrollmessungen durch den Arzt) Z. Geburtshilfe Perinat. 196: 61-62.
72. Hoyme UB, Grosch A, Roemer VM, Saling E (1998): Erste Resultate der Erfurter Frühgeburten-Vermeidungs-Aktion. Z. Geburtshilfe Neonato.l 202: 247-250.
73. Hoyme UB, Möller U, Saling E (2002): Ergebnisse und mögliche Konsequenzen der Thüringer Frühgeburtenvermeidungsaktion 2000. Geburtshilfe Frauenheilk. 62: 257263.
74. Hoyme UB, Saling E (2004a): Effiziente Frühgeburtenvermeidung -Das Thüringer Modell. Gynakol. Geburtshilfliche Rundsch. 44 (1): 2-9.
75. Hoyme UB, Saling E (2004b): Efficient prematurity prevention is possible by pH-self measurement and immediate therapy of threatening ascending infection. Eur. J. Obstet. Gynecol. Reprod. Biol. 115: 148-153.
76. Hoyme UB, Schwalbe N, Saling E (2005a): Die Effizienz der Thüringer Frühgeburtenvermeidungsaktion 2000 wird durch die Perinatalstatistik der Jahre 2001-2003 bestätigt. Geburtsh. Frauenheil.k 65: 284-288.
77. Hoyme UB, Schwalbe N, Saling E (2005b): Efficient Prematurity Prevention is possible by pH-self measurement and immediate therapy of threatening ascending infection. J. Perinat. Med. 33 Suppl. 1-Oral presentations.
78. Siegmund-Schultze E (2008): pH-Self-Assessment to Reduce the Risk of Preterm Birth. XXI. European Congress of Perinatal Medicine, Istanbul, Turkey, September 10-13, 2008. Oral presentation.
79. BKK Landesverband Nordrhein-Westfalen, Presseservice (2008): " Hallo Baby" -Betriebskrankenkassen in NRW senken Frühgeburtenrate. http://www.bkknrw.de/service/presse/index.php?dbt_mode=viewandid=250 (07.02.2008).
80. Bakketeig LS, Bergsjø P (1998): The epidemiology of preterm birth. In: Kurjak A (ed.): Textbook of Perinatal Medicine. London, New York. 1331-1336.
81. Iams JD, Goldenberg RL, Mercer BM et al. (1998): The preterm prediction study: recurrence risk of spontaneous preterm birth. Am. J. Obstet. Gynecol. 178: 1035-1040.
82. Mercer, Brian M. MD; Goldenberg, Robert L. MD et al. (1999): The Preterm Prediction Study: Effect of gestational age and cause of preterm birth on subsequent obstetric outcome. Am. J. Obstet. Gynecol. 181 (5, Part 1): 1216-1221.
83. McManemy, J, Cooke, E, Amon E, Leet T (2007): Recurrence risk for preterm delivery. Am. J. Obstet. Gynecol. 196: 567.e1-567.e7.
84. Mazaki-Tovi S, Romero R, Kusanovic JP, Erez O, Pineles BL, Gotsch F, Mittal P, Than NG, Espinoza J, Hassan S (2007): Recurrent Preterm Birth. Semin. Perinatol. 31: 142-158.
85. Romero R (2007a): Prevention of spontaneous preterm birth: the role of sonographic cervical length in identifying patients who may benefit from progesterone treatment. Ultrasound Obstet. Gynecol. 30: 675-686.
86. Romero R, Espinoza J, Erez O, Hassan S (2006a): The role of cervical cerclage in obstetric practice: Can the patient who could benefit from this procedure be identified? Am. J. Obstet. Gynecol. 194: 1-9.
87. Schulze G (2008): [Results of Early Total Cervix Occlusion (ETCO) According to Saling in Multiple Pregnancies-a retrospective study of the period 1995-2005.] Ergebnisse des Frühen Totalen Muttermundverschlusses nach Saling (FTMV) bei Mehrlingsschwangerschaften-eine retrospektive Studie der Jahre 1995-2005 Z. Geburtshilfe Neonatol. 2008 212: 13-17.
88. Nugent RP, Krohn MA, Hillier SL (1991): Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 29: 297-301
89. Leitich, Harald; Brunbauer, Mathias; Bodner-Adler, Barbara; Kaider, Alexandra; Egarter, Christian; Husslein, Peter (2003): Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis. Am. J. Obstet. Gynecol., 188, 3: 752-758.